Lupus
Here are a few notable presentations from Day 3.
BEAT- LUPUS Trial: OP0129 – I would consider this a pilot trial as it only included 52 patients with active SLE, but the gist was that active SLE…
The question as to how autoimmune rheumatic disease patients fare with the COVID vaccine is one being asked in rheumatologists’ offices everywhere this year, and at the EULAR 2021 Virtual Congress,…
2 years 10 months ago
Video: IFN Scores Predict Resistance to Skin Disease During RTX Therapy in Lupus
Dr. Yuz Yusof speaks with Dr. Lucy Carter about abstract OP0134, presented at the virtual #EULAR2021 meeting.
https://t.co/pqr8uRBiRG https://t.co/lhvuYIfI34
2 years 10 months ago
Video: Prevalence of Long Term HCQ in Retinal Toxicity: Dr. Kathryn Dao (@KDAO2011 )
Dr. Kathryn Dao reviews abstract OP0133, "The Prevalence and Risk Factors of Retinal Toxicity Associated with Long-Term Hydroxychloroquine Use", presented at #EULAR2021.
https://t.co/tZyXQhZgLG https://t.co/x6AfItFWEU
2 years 10 months ago
Excellent talk on SLE, APS abs pregancy
⭐️pregnancy counseling is important
⭐️aspirin 81mg in all pregnant SLE pts
⭐️do not discontinue HCQ
⭐️stable LN - can switch MMF to AZA
Abs#6888
#EULAR2021 @RheumNow
2 years 10 months ago
Close call between LLDAS and DORIS Remission as a treat-to-target in #SLE. Thank you for participating in the polls #EULAR2021 @RheumNow https://t.co/r3OnSrmQkH
2 years 10 months ago
Results are out. The majority would use #anifrolumab to treat refractory skin and joints disease #SLE. Thank you for participating in the polls #EULAR2021 @RheumNow https://t.co/wguBCkhZ7B
2 years 10 months ago
6. Rheum disease activity was stable with COVID vaccination.
(RA, PsA, axSpA, SLE - total n = 597)
7/
LB0003 #EULAR2021 @RheumNow https://t.co/xxkrunjPa0
Podcasts
Canary In A Coal Mine (4.19.2024)
Vasculitis Faculty Panel Q&A
Tuesday Night Rheumatology- Vasculitis Mavens
Poster Hall